T

he next time you view promotional information about a prescription drug on your smartphone, don’t be surprised if the risk information is harder to find than the benefits.

A new study by Food and Drug Administration staffers found that risks are not as “equally prominent and accessible” on smartphones, suggesting that many drug makers are not complying with regulations about providing information with so-called “fair balance.” The study was published earlier this week in the Journal of Medical Internet Research.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.